Literature DB >> 32347889

Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Spectrum Disease.

Philip Eliades1, Maíra Fonseca1,2, Joanna Harp1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32347889     DOI： 10.1001/jamadermatol.2019.3731

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  3 in total

Review 1.  Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.

Authors:  Michele L Ramien; Danny Mansour; Neil H Shear
Journal:  Paediatr Drugs       Date:  2022-06-09       Impact factor: 3.022

Review 2.  Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

Authors:  Audrey Jacobsen; Bayanne Olabi; Annie Langley; Jennifer Beecker; Eric Mutter; Amanda Shelley; Brandon Worley; Timothy Ramsay; Arturo Saavedra; Roses Parker; Fiona Stewart; Jordi Pardo Pardo
Journal:  Cochrane Database Syst Rev       Date:  2022-03-11

3.  Reactive infectious mucocutaneous eruption - repeat etanercept after intravenous immunoglobulin: A case report.

Authors:  Rochelle Tonkin; Malika Ladha; Nicole Johnson; William F Astle; Ami Britton; Neil H Shear; Luis Murguía-Favela; Michele Ramien
Journal:  SAGE Open Med Case Rep       Date:  2022-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.